GNMX Holdings
59 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | Moderna Inc | 8.95% | 581 | $114.2K |
| 2 | Thermo Fisher Scientific Inc | 8.72% | 168 | $111.2K |
| 3 | Vertex Pharmaceuticals Inc | 5.83% | 147 | $74.3K |
| 4 | Illumina Inc | 4.85% | 231 | $61.9K |
| 5 | Guardant Health Inc | 3.60% | 273 | $46.0K |
| 6 | Revolution Medicines Inc | 3.42% | 217 | $43.6K |
| 7 | 10X Genomics Inc | 3.38% | 567 | $43.1K |
| 8 | Genmab A/S | 3.06% | 1,064 | $39.0K |
| 9 | Iovance Biotherapeutics Inc | 2.89% | 2,849 | $36.8K |
| 10 | Twist Bioscience Corp | 2.65% | 217 | $33.8K |
| 11 | Incyte Corp | 2.62% | 294 | $33.4K |
| 12 | First American Government Obligations Fund 12/01/2031 | 2.59% | 32,977 | $33.0K |
| 13 | Alnylam Pharmaceuticals Inc | 2.46% | 140 | $31.4K |
| 14 | Bio-Techne Corp | 2.19% | 385 | $27.9K |
| 15 | GRAIL Inc | 2.19% | 210 | $27.9K |
| 16 | QIAGEN NV | 1.92% | 546 | $24.5K |
| 17 | BioMarin Pharmaceutical Inc | 1.91% | 441 | $24.3K |
| 18 | CareDx Inc | 1.87% | 378 | $23.8K |
| 19 | Tempus AI Inc | 1.82% | 329 | $23.1K |
| 20 | Krystal Biotech Inc | 1.78% | 70 | $22.7K |
| 21 | Adaptive Biotechnologies Corp | 1.70% | 826 | $21.7K |
| 22 | Arrowhead Pharmaceuticals Inc | 1.38% | 287 | $17.6K |
| 23 | Schrodinger Inc/United States | 1.36% | 637 | $17.4K |
| 24 | CRISPR Therapeutics AG | 1.35% | 329 | $17.2K |
| 25 | NeoGenomics Inc | 1.28% | 1,022 | $16.3K |
Sector Weights
- Cash & Others: 2.51%
- Healthcare: 95.10%
- Technology: 2.39%
Country Weights
- United States: 90.04%
- Denmark: 2.81%
- Netherlands: 2.61%
- Other: 2.54%
- Switzerland: 2.00%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.